An investigation was undertaken to determine whether analgesics and their derivatives (13 compounds), and anti-inflammatory drugs (4 compounds) had mutagenicity. Rec-assay was used to clarify specific DNA-damaging properties, and the Ames test was used to find back-mutations, using S-9 fractions obtained from the liver of 4 animal species pretreated with polychlorobiphenyl.
Introduction
The mechanism of cancer induction has long been considered to be mutation caused by alteration of the primary structure of DNA [1, 2] . In recent years, an almost linear relationship has been obtained between mutagenic potency determined by the Ames test and carcinogenic potency in animals. It has also been demonstrated by Ames and his colleagues that 90% of known human carcinogens are mutagenic [3, 4] .
Therefore, from the viewpoint of careful and safe drug use, it is important to detect the mutagenicity of drugs. We have demonstrated previously that sulpyrine possesses the strongest mutagenicity among analgesic drugs in widespread use [5] .
On the other hand, the metabolic pathways of compounds, as well as their mutagenic potency, vary in mammalian species [6, 7] . For example, it has been reported that mutagenicity of phenacetin, a component of many analgesic drugs, was detected in the TA 100 system in the presence of liver S-9 from hamster, but not that from rat. Also, YAMAZOE et al. [7] investigated the metabolic activation of Department of Pharmacology, Nihon University School of Dentistry at Matsudo To whom all correspondence should be addressed: Dr. Noboru KUBOY AMA, Department of Pharmacology, Nihon University School of Dentistry at Matsudo, 2-870-1, Sakaecho-Nishi, Matsudo, Chiba 271, JAPAN. Trp-P-2  in  5 experimental  animal  species  in  order  to  clarify  whether  Nhydroxylation  was  a common  pathway  for mutagenic  activation,  and  to clarify  the   differences  in activating  enzymes  among  the  species.  In rats,  the  activity  was  low,   and  hepatic  microsomes  from  hamster  showed  the highest  activity,  although  there   was  no appreciable  difference  between  the  sexes.  Therefore,  S-9 mixes  obtained   from  several  species  are  an  important  factor  for  the  efficient  detection  of mutagenicityr [8, 9] .
In 
Discussion
We investigated whether widely used analgesics, their derivatives, and antiinflammatory drugs possessed mutagenicity.
A trend of weak DNA damage was demonstrated for salicylic acid, which was the most potent DNA-damaging compound among the salicylate derivatives. Modification of the -COOH and -OH groups of salicylic acid decreased this DNA-damaging potency. Mutagenicity for salicylic acid was found by the Ames test using strain TA 100 in the presence of S-9 mix obtained from rat, and for methyl salicylate using strains TA98 and TA 100 in the presence of S-9 mix obtained from hamster. Several investigators [14, 15] have reported that all salicylate derivatives are teratogenic and show fetal toxicity in various animals. There is also evidence that aspirin causes congenital malformation in man [16] . It may be concluded from the results of the present study and those by other investigators [14] [15] [16] that salicylic acid, aspirin and methyl salicylate are potentially carcinogenic compounds.
Phenacetin and its metabolite acetaminophen cause serious side effects, such as renal papillary necrosis [17] [18] [19] , and phenacetin has been reported to produce tumors in the renal pelvis and urinary bladder of rate]. In another case, ISAKA et al. [211 described that the target of phenacetin-induced carcinogenesis was the nasal cavity and urinary tract. SUGIMURA et al. [221, using strains TA98 and TA100 with On the other hand, ARISAWA et al. [25] reported that at a concentration of 0.1 easily reactive with equal or 2-fold amounts of sodium nitrite to give various nitrosation products. In this study, antipyrine, aminopyrine, IPA and SP were clearly demonstrated to have DNA-damaging properties at doses of more than 0.4 mg/disc by Rec-assay, with an almost linear dose-response curve. SP showed mutagenicity using the TA 100 system with rat S-9 mix, but not with TA98. KUBOYAMA[261 has already reported that SP and its metabolites have mutagenicity.
Conclusions
In order to study the mutagenicity of analgesics, their derivatives, and antiinflammatory drugs, the Rec-assay (cold-incubation method) and Ames test were performed. In the Rec-assay, Bacillus subtilis H-17 (Rec+) and M-45 (Rec-) strains were used to assess the presence of DNA-damaging potential. In the Ames test, Salmonella typhimurium strains TA98 and TA 100 were used to reveal backmutation:
Salicylate derivatives, salicylic acid (2 mg), aspirin (5 mg), and benzoic acid (4 mg) showed specific DNA-damaging properties in the Rec-assay. Methyl salicylate reacted with strain TA98 in the presence of hamster S-9 mix, and salicylic acid and methyl salicylate were also demonstrated to be mutagenic using strain TA100 with S-9 mix from rat and hamster.
Weak mutagenicity was demonstrated by acetaminophen and phenacetine with hamster S-9 mix and by phenacetine with guinea pig S-9 mix in the Ames test.
All pyrazolone derivatives except SP produced no DNA damage or mutagenicity under the present experimental conditions. The dose-DNA damage curve for SP was nearly linear. Weak mutagenicity of SP was also found using strain TA 100 with S-9 mix of rat.
When indomethacin, oxyphenbutazone and diclofenac sodium were tested, not only the Rec--strain but also Rec+ was affected at doses of more than 0.1 mg/ disc, indicating that these drugs possessed strong cytotoxicity. In the Ames test, mutagenicity was demonstrated for indomethacin (0.1 mg) and oxyphenbutazone (0.1 mg) using strain TA100 with rat S-9 mix. Therefore, care should be taken with prolonged administration of salicylic acid, methyl salicylate, acetaminophen, phenacetin, SP, indomethacin, oxyphenbutazone and diclofenac sodium.
